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Abstract 
CRISPR-Cas systems provide adaptive immunity against mobile genetic elements, but 
employment of this resistance mechanism is often reported with a fitness cost for the host. 
Whether or not CRISPR-Cas systems are important barriers for the horizontal spread of 
conjugative plasmids, which play a crucial role in the spread of antibiotic resistance, will 
depend on the fitness costs of employing CRISPR-based defences and the benefits of resisting 
conjugative plasmids. To estimate these costs and benefits we measured bacterial fitness 
associated with plasmid immunity using Escherichia coli and the conjugative plasmid 
pOX38-Cm. We find that CRISPR-mediated immunity fails to confer a fitness benefit in the 
absence of antibiotics, despite the large fitness cost associated with carrying the plasmid in 
this context. Similar to many other conjugative plasmids, pOX38-Cm carries a CcdAB toxin-
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antitoxin (TA) addiction system. These addiction systems encode long-lived toxins and short-
lived anti-toxins, resulting in toxic effects following the loss of the TA genes from the 
bacterial host. Our data suggest that the lack of a fitness benefit associated with CRISPR-
mediated defence is due to expression of the TA system before plasmid detection and 
degradation. As most antibiotic resistance plasmids encode TA systems this could have 
important consequences for the role of CRISPR-Cas systems in limiting the spread of 
antibiotic resistance.  
Introduction 
Prokaryotes often carry multiple immune systems (Labrie, et al., 2010, Doron, et al., 2018), 
including a highly sophisticated adaptive immune system known as CRISPR-Cas (Clustered 
Regularly Interspaced Short Palindromic Repeats – CRISPR-associated), reviewed in 
(Marraffini, 2015). This system functions by integrating sequences of viruses, plasmids and 
transposable elements (Barrangou, et al., 2007, Bikard, et al., 2012, Lopez-Sanchez, et al., 
2012) (known as spacers) into CRISPR loci, which subsequently provide immunity against 
re-infection (Barrangou, et al., 2007, Brouns, et al., 2008, Tyson & Banfield, 2008, Datsenko, 
et al., 2012, Swarts, et al., 2012, Yosef, et al., 2012, van Houte, et al., 2016). Conjugative 
plasmids often carry antibiotic resistance genes and therefore play a crucial role in the spread 
of antibiotic resistance (Maiden, 1998, Dionisio, et al., 2002, Svara & Rankin, 2011, 
Carattoli, 2013). Whether CRISPR-dependent immunity to plasmids is important in limiting 
the spread of antibiotic resistance (Marraffini & Sontheimer, 2008, Palmer & Gilmore, 2010, 
Gophna, et al., 2015) depends on the efficacy of the CRISPR-Cas immune system (Hullahalli, 
et al., 2018), and on the fitness cost associated with carrying the plasmid (in the absence of 
antibiotics) and the cost of resistance associated with CRISPR-immunity. Experimental 
observations (Jiang, et al., 2013, Vercoe, et al., 2013) and theory predicts that CRISPR-Cas 
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systems can degenerate if they carry a cost (Levin, 2010, Weinberger, et al., 2012, Iranzo, et 
al., 2013). While large costs are likely when the CRISPR-Cas system behaves maladaptively, 
such as autoimmunity (Stern, et al., 2010, Vercoe, et al., 2013) and the prevention of 
beneficial infection (Bikard, et al., 2012, Jiang, et al., 2013), there may also be costs when the 
system prevents infection by costly genetic elements, for example due to immunopathological 
effects or energetic costs of immune activation (Vale, et al., 2015, Westra, et al., 2015, van 
Houte, et al., 2016, Westra, et al., 2016). Here, we investigate this possibility using 
Escherichia coli and the conjugative F-plasmid pOX38-Cm. Our data show that CRISPR-
mediated immunity against this costly plasmid is associated with a fitness cost under non-
selective conditions. Our data further suggest that this cost of immunity may not only result 
from energetic costs, but is caused by a plasmid-encoded CcdAB toxin-antitoxin (TA) 
addiction system (Ogura & Hiraga, 1983, Jaffe, et al., 1985, Bahl, et al., 2009), which plays a 
critical role in avoiding plasmid curing (Hayes, 2003). Hence, TA systems may limit the 
evolution of bacterial adaptive immunity against plasmids, which could have important 
consequences for the spread of antibiotic resistance.  
Methods 
Bacterial strains  
E. coli K12 Δhns (BW25113) strains, which have a constitutively active CRISPR-Cas system 
(Pul, et al., 2010, Westra, et al., 2010) were used as recipient cells. These strains, which were 
obtained from the KEIO collection, were cured from the kanamycin resistance cassette using 
FLP recombinase (Datsenko & Wanner, 2000) and were engineered to carry synthetic 
CRISPR loci, sequences of which can be found in Table S2. E. coli MC4100 carrying 
pOX38-Cm was used as the donor strain.  
Cloning of spacers, lacZ and CcdA  
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Spacers, lacZ and ccdA were cloned into the recombination cassette located on the previously 
described plasmid pRECOMB-Cr2.1(Westra, et al., 2010). Spacer-containing DNA fragments 
from plasmid pWUR693 and pWUR700 (Westra, et al., 2013) were cloned using the BamHI 
and EcoRI restriction sites of pRECOMB-Cr2.1. The lacZ and ccdA genes were PCR 
amplified from the E. coli K12 W3110 genome and plasmid pOX38-Cm respectively (Figure 
S1, Table S1, Table S2) and cloned using restriction enzymes NotI and KpnI. Resulting 
plasmids were used as a template for PCR amplification using primers BG4452 and BG4453 
(Figure S1, Table S1, Table S2) and the amplicon was subsequently gel purified. E. coli Δhns 
cells containing the plasmid pKD46 were transformed with the amplicon (Datsenko & 
Wanner, 2000), after which the bacteria were plated on LB agar containing kanamycin (50 
mg/L) to select for recombinants. Plated bacteria were grown at 37°C overnight to cure the 
cells from pKD46. Recombination was confirmed using colony PCR and Sanger sequencing 
(GATC Biotech, Germany). 
Growth measurements 
Growth curves of E. coli K12 Δhns (BW25113) and E. coli K12 Δhns (BW25113) carrying 
pOX38-Cm were measured as follows. Bacteria were inoculated 1:100 in 1 L fresh LB 
medium from overnight cultures containing the same optical density and grown at 37°C while 
shaking at 180 rpm (4 replicas per treatment). The optical density (OD600) of the cultures was 
measured every 30 minutes. At each of these time points a sample of 10 or 20 mL was taken. 
Cells were washed with Millipore water and dried overnight at 130°C. The dry weight of the 
bacteria was measured of every sample to determine the specific growth rate (in gram new 
cells·gram cell-1·hour-1). The specific growth rate was determined for the log phase of the 
growth curve and used as a measurement of bacterial fitness.  
Competition experiments 
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Competition experiments were inoculated from overnight cultures grown at 37°C with equal 
optical densities. Competition experiments were performed in microcosms (6 mL LB medium 
in 30 mL glass vials, 6 replicas per treatment), containing 60 μL of every culture used in the 
experiment. Competition experiments were incubated at 37°C at 100 rpm and a daily transfer 
of 120 L of the competition experiments into fresh microcosms was carried out. After two 
days cells were plated on LB agar containing kanamycin (50 mg/L) and X-gal (50 mg/L). 
Colony counting of blue and white colonies was used to determine relative fitness of 
CRISPR-immune (white colonies) and CRISPR-sensitive strains (blue colonies). Experiments 
were performed in presence or absence of pOX38-Cm to measure the effect of plasmid 
presence on the fitness of the bacterial strains. Statistical analysis was performed using 
JMP10 Software. 
Results 
It has previously been shown that the Type I-E CRISPR-Cas adaptive immune system of E. 
coli (Fig. 1A) can effectively protect against conjugative transfer of plasmid pOX38-Cm 
(Westra, et al., 2013), which is a derivative of the well-studied plasmid F and encodes 
chloramphenicol (Cm) resistance. Measurements of the specific growth rates of E. coli hns 
reveal that carrying plasmid pOX38-Cm reduces growth rates with 27% when antibiotics are 
absent (Fig. 1B and Table 1; F1,7 = 50.67, p = 0.0004). Based on the difference in growth rate 
between plasmid-containing and plasmid-free cells in monoculture, CRISPR-mediated 
immunity against the plasmid would be expected to result in a large fitness benefit. To 
measure the relative fitness associated with CRISPR immunity, competition experiments were 
performed between CRISPR-immune and susceptible E. coli K12 derived strains. To this end, 
the genome of E. coli K12 hns was engineered to replace the CRISPR 2.1 locus flanking the 
cas genes with synthetic CRISPR arrays that either target (strain T) plasmid pOX38-Cm or 
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that do not target (non-targeting; strain NT) the plasmid (Fig. 1A). After competing strain T 
and strain NT for two days the resulting relative fitness is approximately one, indicating that 
the two strains have comparable fitness (Fig. 1C; 1-sample t-test, T5 = 1.19, p = 0.29). 
Surprisingly, the presence of a donor strain that carries conjugative plasmid pOX38-Cm did 
not cause a significant fitness increase of the T strain compared to when the plasmid was 
absent (Fig. 1C; F1,11 = 4.23, p = 0.067). These data therefore suggest that the cost of 
immunity is of the same order of magnitude as the cost of carrying the plasmid.  
Given the T and NT strains did not differ in fitness in the absence of the plasmid, we 
hypothesized that the cost of immunity associated with CRISPR-Cas could be due to gene 
expression from the invading plasmid prior to detection by the immune system, analogous to 
the expression of anti-CRISPR genes from phage genomes prior to CRISPR-mediated 
cleavage of the phage genomes (Bondy-Denomy, et al., 2013, Borges, et al., 2018, 
Landsberger, et al., 2018). Although any of the plasmid genes could contribute to this cost, it 
is well documented that expression of plasmid-encoded addiction systems would be 
particularly harmful. Addiction systems prevent plasmid curing, since removal of the plasmid 
results in rapid depletion of the anti-toxin whereas the toxin will persist for longer periods of 
time to eventually cause cell death (Gerdes & Maisonneuve, 2012, Cook, et al., 2013). The 
toxin anti-toxin (TA) system of plasmid pOX38-Cm is encoded by the ccdAB genes; the 
CcdB toxin is neutralized by the CcdA anti-toxin. In the absence of the short-lived CcdA anti-
toxin the CcdB toxin inhibits DNA gyrase, which eventually leads to cell death (Cook, et al., 
2013). 
To test the hypothesis that this TA system contributes to the cost of resistance we 
engineered an E. coli strain to express the CcdA anti-toxin from the genome in addition to 
carrying the T CRISPR (TccdA strain; Fig. 1A). This strain is immune to plasmid pOX38-Cm 
and to the detrimental effect of toxin CcdB since the toxin is neutralized by CcdA. 
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Competition between the TccdA and the NT strain in the absence of the conjugative plasmid 
reveals that encoding CcdA on the genome is associated with a fitness cost (relative fitness = 
0.37) (Fig. 1D; T5 = -19.2, p < 0.0001) after two days of competition. By contrast, when 
competing TccdA and NT for two days in the presence of a donor strain that carries the 
pOX38-Cm plasmid, the TccdA strain has a large fitness benefit (relative fitness = 15.2) (Fig. 
1D; T5 = 3.5, p = 0.017). Hence these data demonstrate that expression of the antitoxin from 
the bacterial chromosome alleviates the cost of CRISPR immunity, suggesting that TA 
expression from the plasmid prior to its degradation by CRISPR-Cas immune systems may be 
an important contributor to the observed cost of immunity.  
Discussion 
Costs of resistance potentially have profound effects on co-evolutionary dynamics (Agrawal 
& Lively, 2003, Lopez-Pascua & Buckling, 2008, Gomez & Buckling, 2011, Buckling & 
Brockhurst, 2012) and are directly responsible for the existence of trade-offs between 
immunity and other life-history traits (Boots & Begon, 1993, Boots & Bowers, 2004, Little & 
Killick, 2007, Kempel, et al., 2011). Our data suggest that TA systems encoded by plasmids 
may cause CRISPR immunity against an invading plasmid to be costly, due to the time-lag 
between infection and clearance of the infection during which the TA system may already be 
expressed. As a result of this cost the CRISPR system may have little net benefit against 
costly plasmids if they encode TA-systems. This could explain the limited spread and 
degeneration of CRISPR-Cas systems, and may also help to explain observations of high 
degrees of susceptibility to costly plasmids in E. coli (Touchon, et al., 2012). Furthermore, 
many antibiotic resistance genes are carried on conjugative plasmids containing TA systems 
(Maiden, 1998, Dionisio, et al., 2002, Svara & Rankin, 2011, Carattoli, 2013). As such, there 
will be relatively weak selection to resist these plasmids via CRISPR-Cas, even in the absence 
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of antibiotic selection. Our findings also indicate that using CRISPR-Cas as a tool to 
resensitize bacteria to antibiotics by selectively removing antibiotic resistance-carrying 
conjugative plasmids (Pursey, et al., 2018) may be challenging when these plasmids encode 
TA systems. 
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Figure 1. (A) Overview of the engineered CRISPR locus of the T strain (targeting pOX38-
Cm), the NT strain (not targeting pOX38-Cm, encoding LacZ) and the TccdA strain (targeting 
pOX38-Cm, encoding CcdA). Genes are indicated by arrows. The CRISPR locus consists of 
repeats (black) and spacers (white). The spacer targeting pOX38-Cm is indicated by 
horizontal stripes. B) Optical densities at 600 nm (OD600) of plasmid-free (hns) cells and 
plasmid-containing (hns+pOX38-Cm) cells at different time points after inoculation. 
Measurements of dry weight were used to determine specific growth rates (g new cells·g cells-
1·hour-1, Table 1). C) Relative fitness (mean ± 95% CI) of T strain in the absence or presence 
of the pOX38-Cm donor strain after two days of competition with NT strain. D) Relative 
fitness (mean ± 95% CI) of TccdA strain in the absence or presence of the pOX38-Cm donor 
strain after two days of competition with NT strain.  
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Table 1. Specific growth rates of bacteria with and without plasmid pOX38-Cm. 
 
Strain Specific growth rate (g new cells*g cells
-1
*hour
-1
) 
hns 0.90 ± 0.06 
hns + pOX38-Cm 0.66 ± 0.04 
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